Found 8 matching trials
Octreotide LAR as Maintenance Treatment for Patients With NEC PHASE2 This is phase II study on the efficacy of octreotide lar as maintenance tre...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly PHASE3 This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Show More Location
University of Michigan
Learn More & Join Trial
Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors PHASE2 The purpose of this study is to examine if PTK787/ZK222584 (vatalanib) will...
Show More Location
Neuroendocrine Clinic
Learn More & Join Trial
Acromegaly Combination Treatment Study NA In this study the investigators will evaluate whether combination low dose ...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas PHASE2 Assess whether therapy with axitinib, a potent angiogenic inhibitor of the ...
Show More Location
Marburg Universitätsklinikum Giessen und Marburg GmbH
Learn More & Join Trial
Sandostatin for Patients With Androgen Independent Prostate Cancer PHASE2 This is an open label, single center Phase II trial of Sandostatin LAR in p...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET PHASE1 Purpose: Castrate resistance prostate cancer (CRPC) often shows histologica...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis PHASE1 Octreotide is used to control variceal bleeding. However, octreotide has to...
Show More Location
Multiple Locations
Learn More & Join Trial